Hubbry Logo
CalystaCalystaMain
Open search
Calysta
Community hub
Calysta
logo
7 pages, 0 posts
0 subscribers
Be the first to start a discussion here.
Be the first to start a discussion here.
Calysta
from Wikipedia

Calysta is a privately held biotechnology company based in California that develops and commercializes microbial protein ingredients through gas-fermentation technology for use in animal feed and other food applications. Calysta uses methanotrophic bacteria to ferment methane into single-cell protein ingredients designed for aquaculture and livestock feed applications.[1] It also uses other food ingredients.[2][3]

Key Information

Beginning in 2016, Calysta had operated a demonstration plant in Teesside, England,[4] that used methanotroph bacteria to convert methane into FeedKind® single cell protein[5] under a UK government grant. The product received approval for inclusion in fish and livestock feed in the European Union.[4][6] The facility was later decommissioned as the company shifted away from pilot-scale operations.

Calysta was founded in 2012, based on technology developed by scientists associated with DNA2.0 (now ATUM), a US synthetic biology company. Calysta secured venture funding to commercialize its methane-to-protein technology.[7]

History

[edit]

Calysta was founded in 2012 in Menlo Park, California[2][8] by Josh Silverman,[4] and is led by CEO Alan Shaw.[1][9]

By June 2013, the firm began working with NatureWorks to use methane fermentation to produce lactic acid.[10][11] Calysta’s methane-based protein fermentation approach builds on earlier research into gas-fermentation processes, including work conducted by Statoil in the 1980s.[12] In 2014, Calysta purchased and further developed the technology for producing animal feed ingredients.[6] Using the ten-million-dollar total funding from investors including Aqua-Spark,[13] Calysta began a study to determine the viability of a mass production facility.[14]

In 2016 Calysta opened a pilot protein production facility in Teesside, England with £2.8 million ($3.7 million) in UK Government support; that site has since been decommissioned as the company focuses on commercial-scale manufacturing in Chongqing, China.[15] In early 2016, the firm announced it had raised $30 million in funding led by Cargill, an American agribusiness corporation.[12]

The firm's Teesside facility opened in September 2016.[16] The facility is dedicated to the production of the company's chief product, "FeedKind protein."[17] The firm raised an additional $40 million in May 2017 from existing and new investors including Japan's Mitsui & Co. and Singapore's Temasek Holdings.[1][18][19] The firm recently completed its first commercial scale production facility in Chongqing, China with a capacity of 20,000 tonnes of product per year.[20]

Operations

[edit]

Calysta's processes rely on methanotrophs (specifically Methylococcus capsulatus[6]) which naturally convert methane into methanol by the enzyme, methane monooxygenase.[21] Calysta’s process uses naturally occurring methanotroph bacteria to produce single-cell protein without genetic modification, intended for use in commercial aquaculture and livestock feeds.[6][22][23] Protein produced from methane is being offered as a substitute or supplement in the farmed fish industry which conventionally employs fishmeal and fish oil as its source of protein.[13]

The company's manufacturing facilities have been using natural gas as their source of methane. Plans for a U.S. manufacturing facility reported before 2019[1][24][25] have not been documented in later independent coverage; as of 2025, Calysta’s primary commercial production occurs at its industrial-scale plant in Chongqing, China.

References

[edit]
[edit]
Revisions and contributorsEdit on WikipediaRead on Wikipedia
Add your contribution
Related Hubs
User Avatar
No comments yet.